Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$17,595,639
+$9,391,291 QoQ
Shares Held
14,670
+64.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.43%
of 13F equity value
Holder Rank
#952
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PAYDEN & RYGEL holds $102,478,534 across 7 Drug Manufacturers - General names. LLY ranks #3 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
200,960 | $25,823,360 | |
| 2 | ABBV |
AbbVie Inc.
|
73,250 | $18,432,630 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
14,670 | $17,595,639 | |
| 4 | JNJ |
Johnson & Johnson
|
64,900 | $16,482,653 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
126,560 | $15,989,590 | |
| 6 | PFE |
Pfizer Inc
|
311,580 | $7,502,846 | |
| 7 | AMGN |
Amgen Inc
|
1,800 | $651,816 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,595,639 | 14,670 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $8,204,348 | 8,920 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,245,533 | 3,020 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,380,560 | 3,120 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $12,254,211 | 15,720 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $12,983,305 | 15,720 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,349,440 | 9,520 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $11,091,968 | 12,520 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $21,928,303 | 24,220 | Shares | Sole | 2024-10-07 | |
| 2024-03-31 | $20,631,499 | 26,520 | Shares | Sole | 2024-10-08 | |
| 2023-12-31 | $17,440,966 | 29,920 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $16,070,929 | 29,920 | Shares | Sole | 2024-10-07 | |
| 2023-06-30 | $14,407,065 | 30,720 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $36,172,428 | 105,330 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $43,864,216 | 119,900 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $48,211,485 | 149,100 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $49,509,921 | 152,700 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $43,821,769 | 153,025 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $40,859,843 | 147,925 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $34,593,961 | 149,725 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $26,905,482 | 117,225 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,774,229 | 9,497 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $40,622,904 | 240,600 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $35,613,612 | 240,600 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $38,303,194 | 233,300 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $44,140,704 | 318,200 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||